ASX - Delayed Quote AUD

Neuren Pharmaceuticals Limited (NEU.AX)

Compare
13.13 +0.02 (+0.15%)
At close: October 18 at 4:10 PM GMT+11
Currency in AUD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
231,925.00
231,925.00
14,553.00
--
--
Gross Profit
231,925.00
231,925.00
14,553.00
--
--
Operating Expense
32,714.00
32,714.00
16,159.00
11,438.00
9,532.00
Operating Income
199,211.00
199,211.00
-1,606.00
-11,438.00
-9,532.00
Net Non Operating Interest Income Expense
5,687.00
5,687.00
391.00
41.00
147.00
Other Income Expense
225.00
225.00
1,389.00
3,595.00
186.00
Pretax Income
205,140.00
205,140.00
184.00
-7,794.00
-9,193.00
Tax Provision
48,059.00
48,059.00
--
--
--
Net Income Common Stockholders
157,081.00
157,081.00
184.00
-7,794.00
-9,193.00
Basic EPS
1.24
1.24
0.00
-0.07
-0.09
Diluted EPS
1.20
1.20
0.00
-0.07
-0.09
Basic Average Shares
127,069.51
127,069.51
125,965.68
117,770.05
107,057.32
Diluted Average Shares
130,791.84
130,791.84
125,965.68
117,770.05
107,057.32
Net Income from Continuing & Discontinued Operation
157,081.00
157,081.00
184.00
-7,794.00
-9,193.00
Normalized Income
157,081.00
157,081.00
184.00
-7,794.00
-9,193.00
Interest Income
5,687.00
5,687.00
391.00
41.00
147.00
Net Interest Income
5,687.00
5,687.00
391.00
41.00
147.00
EBIT
199,211.00
199,211.00
-1,606.00
-11,438.00
-9,532.00
EBITDA
199,228.00
199,228.00
-1,596.00
-11,430.00
-9,526.00
Reconciled Depreciation
17.00
17.00
10.00
8.00
6.00
Net Income from Continuing Operation Net Minority Interest
157,081.00
157,081.00
184.00
-7,794.00
-9,193.00
Normalized EBITDA
199,228.00
199,228.00
-1,596.00
-11,430.00
-9,526.00
Tax Rate for Calcs
0.00
0.00
--
--
--
12/31/2020 - 2/1/2005

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers